首页> 外国专利> Asthma associated factors as targets for treating atopic allergies including asthma and related disorders

Asthma associated factors as targets for treating atopic allergies including asthma and related disorders

机译:哮喘相关因素作为特应性过敏症(包括哮喘和相关疾病)的治疗目标

摘要

#$%^&*AU2011265475A120120119.pdf#####ABSTRACT A C to T DNA variation at position 3365 in exon 5 of the human Asthma Associated Factor 1 (AAF1) produces the predicted amino acid substitution of a methionine for a threonine at codon 117 of AAFL. When this substitution occurs in both alleles in one individual, it is associated with less evidence of atopic allergy including asthma, fewer abnormal skin test responses, and a lower serum total IgE. Thus, applicant has identified the existence of a non-asthmatic, non-atopic phenotype characterized by methionine at codon 117 when it occurs in both AAFI gene products in one individual.
机译:#$%^&* AU2011265475A120120119.pdf #####抽象人类哮喘第5外显子在3365位的C到T DNA变异相关因子1(AAF1)产生一个预期的氨基酸取代于AAFL密码子117的苏氨酸的蛋氨酸。当这种替换发生在一个人的两个等位基因,与特应性过敏的证据较少相关包括哮喘,较少的异常皮肤测试反应和较低的血清总IgE。因此,申请人确定存在非哮喘,非特应性表型当两个AAFI基因产物中都存在甲硫氨酸时,其密码子为117一个人

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号